Skip to Main Content
TABLE 1

Baseline characteristics

Diabetic subjectsNondiabetic subjects
n 127 5,118 
Age (years) 55.6 ± 5.7 55.3 ± 5.5 
BMI (kg/m227.8 ± 3.7 25.9 ± 3.1 
Alcohol (units/week) 11 ± 15 11 ± 13 
Smoking (Y/N) 58 (46) 2,222 (43) 
Pravastatin therapy 52 (41) 2,579 (50) 
Systolic blood pressure (mmHg) 138 ± 17 135 ± 17 
Diastolic blood pressure (mmHg) 85 ± 10 84 ± 10 
Hypertension (Y/N) 34 (27) 793 (15) 
Ln(triglyceride) [ln(mmol/l)] 0.78 ± 0.39 0.51 ± 0.40 
Total cholesterol (mmol/l) 7.18 ± 0.61 7.02 ± 0.58 
HDL cholesterol (mmol/l) 1.04 ± 0.20 1.14 ± 0.24 
Total cholesterol–to–HDL cholesterol ratio 7.15 ± 1.48 6.41 ± 1.36 
Glucose (mmol/l) 5.48 ± 0.70 4.69 ± 0.49 
Ln(WCC) [ln(109 cells/l)] 1.94 ± 0.26 1.84 ± 0.27 
Ln(sensitive CRP) [ln(mg/l)] 1.05 ± 0.90 0.53 ± 1.08 
Diabetic subjectsNondiabetic subjects
n 127 5,118 
Age (years) 55.6 ± 5.7 55.3 ± 5.5 
BMI (kg/m227.8 ± 3.7 25.9 ± 3.1 
Alcohol (units/week) 11 ± 15 11 ± 13 
Smoking (Y/N) 58 (46) 2,222 (43) 
Pravastatin therapy 52 (41) 2,579 (50) 
Systolic blood pressure (mmHg) 138 ± 17 135 ± 17 
Diastolic blood pressure (mmHg) 85 ± 10 84 ± 10 
Hypertension (Y/N) 34 (27) 793 (15) 
Ln(triglyceride) [ln(mmol/l)] 0.78 ± 0.39 0.51 ± 0.40 
Total cholesterol (mmol/l) 7.18 ± 0.61 7.02 ± 0.58 
HDL cholesterol (mmol/l) 1.04 ± 0.20 1.14 ± 0.24 
Total cholesterol–to–HDL cholesterol ratio 7.15 ± 1.48 6.41 ± 1.36 
Glucose (mmol/l) 5.48 ± 0.70 4.69 ± 0.49 
Ln(WCC) [ln(109 cells/l)] 1.94 ± 0.26 1.84 ± 0.27 
Ln(sensitive CRP) [ln(mg/l)] 1.05 ± 0.90 0.53 ± 1.08 

Data for continuous measurements are means ± SD, and for categorical measurements, n (%). Baseline characteristics of subjects who had at least two post-randomization measurements of glucose, were not self-reported diabetic patients at baseline and did not have a fasting glucose at baseline ≥7.0 mmol/l, and had baseline plasma available for CRP measurements. Ln, natural logarithm.

Close Modal

or Create an Account

Close Modal
Close Modal